Search

Search Constraints

You searched for: Author/Creator Stannard, Kimberley

Search Results

1. CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity. (4th May 2018)

4. Systemic administration of IL‐33 induces a population of circulating KLRG1hi type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma. Issue 1 (18th September 2020)

5. Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis. (1st February 2017)

6. The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor‐infiltrating T cells. Issue 2 (17th October 2018)